<DOC>
	<DOCNO>NCT00881725</DOCNO>
	<brief_summary>This study investigate effect neoadjuvant metformin therapy inhibition growth proliferation prostate cancer cell prior radical prostatectomy .</brief_summary>
	<brief_title>A Study Pre-operative Metformin Prostate Cancer</brief_title>
	<detailed_description>Prostate cancer commonly diagnose malignancy men North America , close quarter million case diagnosed 2007 alone ( Joshua et al , 2007 ) . The activation PTEN/ AKT pathway think importance prostatic carcinogenesis correlate poor prognosis ( Yoshimoto et al , 2007 ) ( Schmitz et al , 2007 ) . Components cellular pathway pleiotropic target include mTOR complex . In model system , tumour exhibit activation PI3K/AKT kinase sensitive mTOR inhibitor . Metformin ( 1,1-dimethylbiguanide hydrochloride ) belong biguanide class oral hypoglycaemic agent commonly prescribe medication number condition . It first-line drug choice treatment type 2 diabetes . Its mechanism action think primary inhibition hepatic glucose output inhibition gluconeogenesis . Subsequently , metformin cause decline circulate insulin level ( Hundal et al , 2000 ) . Metformin cause inhibition mTOR complex . The mTOR complex primarily inhibit activation AMPK ( component PTEN/AKT pathway ) . Metformin cause reduce hepatic glucose output lead decreased level circulate insulin cause secondary inhibition mTOR complex . Metformin also show inhibit cyclin D1 expression retinoblastoma protein ( Rb ) phosphorylation . Inhibition Cyclin D1 Rb phosphorylation cause inhibition G1/S phase transition cell cycle . This result inhibition cell proliferation ( Matsushime et al , 1994 ) . This study investigate effect neoadjuvant metformin therapy inhibition growth proliferation prostate cancer cell prior radical prostatectomy .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>1 . 1 . Patients histologically confirm prostate cancer involve least 20 % least one unfragmented biopsy core ; 2 . Over age 18 age 75 ; 3 . Ability read understand consent form , either alone aid translator 4 . ECOG performance status less equal 2 ( Karnofsky great equal 60 % ) ; 5 . Patients must TRUS biopsy perform UHN ( outside institution tissue accession arrange ) last 3 month ; 6 . Patients must normal organ marrow function define follow criterion : 1 . Absolute neutrophil count great equal 1,500/uL 2 . Platelets great equal 100,000/uL 3 . Total bilirubin less equal 1.5 X institutional ULN 4 . AST ( SGOT ) /ALT ( SGPT ) less equal 1.5 X institutional ULN 5 . Creatinine le equal 1.4 X institutional ULN 1 . Patients initial assessment find treatment drug use treatment form diabetes , patient begin treatment form diabetes course study ; 2 . Patients may receive investigational , herbal anticancer agent study ; 3 . Uncontrolled intercurrent illness include , limited , ongoing active infection , congestive heart failure ( NYHA Class 3 great ) , cirrhosis ChildPugh level B great evidence cardiac dysfunction , unstable angina pectoris , cardiac arrhythmia , active peptic ulcer disease , clinically significant gastrointestinal condition ( e.g . Crohns disease , ulcerative colitis ) , COPD psychiatric illness/social situation would limit compliance study requirement ; 4 . Active malignancy site exclude squamous cell basal cell carcinoma skin 5 . Radiotherapy within past 4 week ; 6 . Patients current history alcohol intake ( &gt; 2 standard drinks/day ) binge drinking ( 5 drink ( male ) , 4 drink ( female ) ) one session 13 hour ; 7 . Past history lactic acidosis risk factor lactic acidosis congestive heart failure ( NYHA Class 3 great ) , hypoxia ( rest PO2 &lt; 91 % ) renal insufficiency ( eGFR &lt; 60 mls/min ) 8 . Patients take systemic glucocorticoid estrogenic compound . 9 . Patients know hypersensitivity allergy metformin excipients . 10 . Patients history impair liver kidney function .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Metformin</keyword>
	<keyword>Prostate Cancer</keyword>
	<keyword>Radical Prostatectomy</keyword>
	<keyword>Neoadjuvant Intervention</keyword>
	<keyword>PTEN/AKT Pathway</keyword>
	<keyword>Tumour Expression</keyword>
	<keyword>Ki67 Expression</keyword>
</DOC>